You have 9 free searches left this month | for more free features.

lomustine

Showing 1 - 25 of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

First Progression of Glioblastoma Trial (Lomustine, Reirradiation)

Not yet recruiting
  • First Progression of Glioblastoma
  • Lomustine
  • Reirradiation
  • (no location specified)
Jun 6, 2023

First Progression of MGMT Promoter-methylated Glioblastoma Trial in Bellinzona, Zürich (Lomustine, Romiplostim)

Recruiting
  • First Progression of MGMT Promoter-methylated Glioblastoma
  • Barcelona, Spain
  • +4 more
Nov 16, 2022

Glioblastoma Trial in San Antonio (Lomustine, Imipramine Hydrochloride)

Recruiting
  • Glioblastoma
  • Lomustine
  • Imipramine Hydrochloride
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
Jul 21, 2022

Glioblastoma Trial (Onfekafusp alfa, Lomustine)

Not yet recruiting
  • Glioblastoma
  • Onfekafusp alfa
  • Lomustine
  • (no location specified)
Apr 19, 2022

Recurrent Glioblastoma Trial (MTX110, Programmable pump and catheter system, Lomustine)

Recruiting
  • Recurrent Glioblastoma
  • Jacksonville, Florida
  • +1 more
Jan 26, 2023

Glioblastoma Trial in Zürich (L19TNF, Lomustine)

Recruiting
  • Glioblastoma
  • Zürich, Switzerland
    Universitatspital Zurich - Klinik fur Neurologie & Hirntumorzent
Apr 19, 2022

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
  • IDH Family Wildtype
  • +2 more
  • Laser Interstitial Thermal Therapy
  • Lomustine
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • SonoCloud-9 (SC9)
  • +3 more
  • Chicago, Illinois
  • +7 more
Jun 5, 2023

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Static Magnetic and Electric (sBE) device
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 20, 2022

Solid Tumors (Phase 1), Relapsed/Recurrent GBM (Phase 2) Trial in Spain, United States (USL311, Lomustine)

Terminated
  • Solid Tumors (Phase 1)
  • Relapsed/Recurrent GBM (Phase 2)
  • Saint Louis, Missouri
  • +5 more
Jul 1, 2021

Glioblastoma Multiforme, Cognition Disorders, Disability Evaluation Trial in Den Haag, Rotterdam (biological, drug, genetic,

Completed
  • Glioblastoma Multiforme
  • +2 more
  • bevacizumab
  • +5 more
  • Den Haag, Netherlands
  • +1 more
Feb 11, 2021

High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,

Active, not recruiting
  • High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
  • Fullerton, California
  • +2 more
Jun 13, 2022

Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

Active, not recruiting
  • Anaplastic Astrocytoma
  • Recurrent Anaplastic Astrocytoma
  • Birmingham, Alabama
  • +78 more
Jan 19, 2022

Glioblastoma, Diffuse Glioma Trial in Worldwide (NMS-03305293 + TMZ, Lomustine)

Recruiting
  • Glioblastoma
  • Diffuse Glioma
  • NMS-03305293 + TMZ
  • Lomustine
  • Rochester, Minnesota
  • +3 more
Mar 11, 2022

Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • VBI-1901
  • +2 more
  • Los Angeles, California
  • +3 more
Jun 27, 2022

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Atlanta (Liothyronine, Lomustine, Methimazole)

Recruiting
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 23, 2022

Glioblastoma Multiforme Trial in Italy (Regorafenib, Lomustine)

Active, not recruiting
  • Glioblastoma Multiforme
  • Castellana Grotte, BA, Italy
  • +9 more
Mar 31, 2022

Recurrent Glioblastoma Multiforme Trial in Worldwide (buparlisib, carboplatin, lomustine)

Completed
  • Recurrent Glioblastoma Multiforme
  • Phoenix, Arizona
  • +13 more
Dec 6, 2020

Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • Amsterdam, Netherlands
  • +2 more
Apr 14, 2021

Glioblastoma Multiforme, Adult Trial in Worldwide (Berubicin, Lomustine)

Recruiting
  • Glioblastoma Multiforme, Adult
  • Phoenix, Arizona
  • +49 more
Aug 17, 2022

Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)

Active, not recruiting
  • Glioblastoma
  • LY2157299 monohydrate
  • +2 more
  • Birmingham, Alabama
  • +26 more
Oct 18, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Lomustine
  • +4 more
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022